VEOZA fezolinetant 45 mg film coated tablet blister pack

Страна: Австралия

Език: английски

Източник: Department of Health (Therapeutic Goods Administration)

Активна съставка:

fezolinetant, Quantity: 45 mg

Предлага се от:

Astellas Pharma Australia Pty Ltd

Лекарствена форма:

Tablet, film coated

Композиция:

Excipient Ingredients: mannitol; hyprolose; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; purified talc; iron oxide red

Начин на приложение:

Oral

Броя в опаковка:

30 tablets, 100 tablets, 10 tablets (starter pack)

Вид предписание :

(S4) Prescription Only Medicine

Терапевтични показания:

VEOZA is indicated for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause (see section 5.1 Pharmacodynamic Properties ? Clinical Trials)

Каталог на резюме:

Visual Identification: Fezolinetant 45 mg tablets are round, light red, film coated tablets debossed with the Astellas logo and 645 on the same side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Статус Оторизация:

Registered